BioCentury
ARTICLE | Company News

Versicor receives second milestone from Novartis

November 15, 2000 8:00 AM UTC

VERS received a milestone payment from partner Novartis (SWX:NOVN; NVS) for delivery of an assay to identify anti-infective peptide deformylase inhibitor drug candidates. Under the collaboration, NOVN...